Van Hulzen Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-1,683
| Closed | -$218K | – | 234 |
|
|
2018
Q2 | $218K | Buy |
+1,683
| New | +$218K | 0.06% | 175 |
|
|
2017
Q3 | – | Sell |
-2,749
| Closed | -$208K | – | 186 |
|
|
2017
Q2 | $208K | Buy |
+2,749
| New | +$208K | 0.08% | 129 |
|
|
2016
Q4 | – | Sell |
-1,771
| Closed | -$113K | – | 152 |
|
|
2016
Q3 | $113K | Buy |
+1,771
| New | +$113K | 0.06% | 143 |
|